June 01, 2022 | New York Law Journal
The 'Amgen v. Sanofi' Enablement Battle and Best Practices in Light of the Federal Circuit's §112(a) Opinion on Broad, Functional Genus ClaimsThe Supreme Court will hopefully establish clear precedent sooner rather than later, especially since the question goes to the very heart of the quid pro quo bargain that the American patent system is based upon.
By Jessica H. Zafonte and Joseph V. Saphia
12 minute read